BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Han LL, Lv Y, Guo H, Ruan ZP, Nan KJ. Implications of biomarkers in human hepatocellular carcinoma pathogenesis and therapy. World J Gastroenterol 2014; 20(30): 10249-10261 [PMID: 25132742 DOI: 10.3748/wjg.v20.i30.10249]
URL: https://www.wjgnet.com/1948-5182/full/v20/i30/10249.htm
Number Citing Articles
1
Zhiquan Zhang, Bao Lei, Wei Chai, Ruhai Liu, Tiejun Li. Increased expression of insulin-like growth factor-1 receptor predicts poor prognosis in patients with hepatocellular carcinomaMedicine 2019; 98(44): e17680 doi: 10.1097/MD.0000000000017680
2
Jiaming Qi, Jiaxing Zhou, Xu-Qing Tang, Yaolai Wang. Gene Biomarkers Derived from Clinical Data of Hepatocellular CarcinomaInterdisciplinary Sciences: Computational Life Sciences 2020; 12(2): 226 doi: 10.1007/s12539-020-00366-8
3
Lin Chen, Feihu Chu, Yali Cao, Jianguo Shao, Feng Wang. Serum miR-182 and miR-331-3p as diagnostic and prognostic markers in patients with hepatocellular carcinomaTumor Biology 2015; 36(10): 7439 doi: 10.1007/s13277-015-3430-2
4
Ahmad Khan, Xiaobo Zhang. Function of the Long Noncoding RNAs in Hepatocellular Carcinoma: Classification, Molecular Mechanisms, and Significant Therapeutic PotentialsBioengineering 2022; 9(8): 406 doi: 10.3390/bioengineering9080406
5
Marwa Sayed Abdel-Tawab, Hanan Fouad, Doaa Mahmoud Khalil, Saeed Shaaban, Shaymaa Nafady, Hanan Hosni Moawad, Heba Ahmed Mostafa, Soha Mahmoud Abdel-Salam, Naglaa Adly Abd Elazeem, Alaa A. Mohamed. The role of miRNA-29b1, MMP-2, MMP-9 mRNAs, and proteins in early diagnosis of HCCEgyptian Journal of Medical Human Genetics 2023; 24(1) doi: 10.1186/s43042-023-00434-w
6
Hai-Feng Zhang, Wei Li, Yi-Di Han. LINC00261 suppresses cell proliferation, invasion and Notch signaling pathway in hepatocellular carcinomaCancer Biomarkers 2018; 21(3): 575 doi: 10.3233/CBM-170471
7
Wei Song, Yuejun Gu, Sen Lu, Huazhang Wu, Zhenxing Cheng, Jiaojiao Hu, Yanyan Qian, Ying Zheng, Hong Fan. LncRNA TRERNA1 facilitates hepatocellular carcinoma metastasis by dimethylating H3K9 in the CDH1 promoter region via the recruitment of the EHMT2/SNAI1 complexCell Proliferation 2019; 52(4) doi: 10.1111/cpr.12621
8
Long Liu, Qi Wang, Xiaohong Zhao, Yuxi Huang, Yuyi Feng, Yu Zhang, Zheping Fang, Shaowei Li. Establishment and validation of nomogram model for the diagnosis of AFP-negative hepatocellular carcinomaFrontiers in Oncology 2023; 13 doi: 10.3389/fonc.2023.1131892
9
Areeg M. Dabbish, Hana M. Abdelzaher, Moustafa Abohawya, Samir Shamma, Yosra H. Mahmoud, Amr Maged, Mohamed Manaa, Mohamed Hassany, Firas Kobeissy, Omid Bazgir, Hassan El-Fawal, Hassan M. E. Azzazy, Anwar Abdelnaser. Prognostic MicroRNA Panel for HCV-Associated HCC: Integrating Computational Biology and Clinical ValidationCancers 2022; 14(13): 3036 doi: 10.3390/cancers14133036
10
Gang Chen, Dongdong Wang, Xiongqi Zhao, Jun Cao, Yingpeng Zhao, Fan Wang, Jianhua Bai, Ding Luo, Li Li. miR-155-5p modulates malignant behaviors of hepatocellular carcinoma by directly targeting CTHRC1 and indirectly regulating GSK-3β-involved Wnt/β-catenin signalingCancer Cell International 2017; 17(1) doi: 10.1186/s12935-017-0469-8
11
Po-Li Wei, Chien-Yu Huang, Yu-Jia Chang, Yi-Hsien Hsieh. Propyl gallate inhibits hepatocellular carcinoma cell growth through the induction of ROS and the activation of autophagyPLOS ONE 2019; 14(1): e0210513 doi: 10.1371/journal.pone.0210513
12
Song He, Xiao-Wu Hu, Dong Wang, Ling-Fei Han, De-chun Zhang, Cheng Wei. Accuracy of microRNAs for the diagnosis of hepatocellular carcinoma: A systematic review and meta-analysisClinics and Research in Hepatology and Gastroenterology 2016; 40(4): 405 doi: 10.1016/j.clinre.2016.02.001
13
Wenlong Wu, Quancheng Wang, Dandan Han, Jianhui Li, Ye Nie, Dongnan Guo, Long Yang, Kaishan Tao, Xuan Zhang, Kefeng Dou. Prognostic value of preoperative inflammatory markers in patients with hepatocellular carcinoma who underwent curative resectionCancer Cell International 2021; 21(1) doi: 10.1186/s12935-021-02204-3
14
Eman A. E. Badr, Elshaymaa I. Elmongy, Rasha Galal Mostafa, Ibrahim El-Tantawy El-Sayed, Abd El-Naser Abd El-Ati Gad Allah, Asmaa Khairy Ahmed, Yasser A. S. Elghobashy. The Role of LINC01564, RAMS11, CBX4 and TOP2A in Hepatocellular CarcinomaBiomedicines 2022; 11(1): 56 doi: 10.3390/biomedicines11010056
15
Yao-Li Chen, Shih-Hsuan Chan, Ping-Yi Lin, Pei-Yi Chu. The expression of a tumor suppressor gene JDP2 and its prognostic value in hepatocellular carcinoma patientsHuman Pathology 2017; 63: 212 doi: 10.1016/j.humpath.2017.03.003
16
Zhenggang Wu, Xi Long, Shui Ying Tsang, Taobo Hu, Jian-Feng Yang, Wai Kin Mat, Hongyang Wang, Hong Xue. Genomic subtyping of liver cancers with prognostic applicationBMC Cancer 2020; 20(1) doi: 10.1186/s12885-020-6546-8
17
Zhaobo Liu, Min Wu, Dongdong Lin, Ning Li. Des-gamma-carboxyprothrombin is a favorable biomarker for the early diagnosis of alfa-fetoprotein-negative hepatitis B virus-related hepatocellular carcinomaJournal of International Medical Research 2020; 48(2): 030006052090257 doi: 10.1177/0300060520902575
18
Jing Lv, Hong-xia Fan, Xiao-pei Zhao, Ping Lv, Jing-yi Fan, Yi Zhang, Min Liu, Hua Tang. Long non-coding RNA Unigene56159 promotes epithelial–mesenchymal transition by acting as a ceRNA of miR-140-5p in hepatocellular carcinoma cellsCancer Letters 2016; 382(2): 166 doi: 10.1016/j.canlet.2016.08.029
19
Bin Zheng, MS, Heng Wang, MS, Jin-xue Wang, MS, Zheng-hong Liu, MS, Pu Zhang, MD, Dahong Zhang, MD. The Clinical Significance of RMI2 in Hepatocellular CarcinomaTechnology in Cancer Research & Treatment 2021; 20: 153303382110454 doi: 10.1177/15330338211045496
20
GUOJUN SUN, SHUQIN ZHANG, YANRU XIE, ZIYU ZHANG, WENJING ZHAO. Gallic acid as a selective anticancer agent that induces apoptosis in SMMC-7721 human hepatocellular carcinoma cellsOncology Letters 2016; 11(1): 150 doi: 10.3892/ol.2015.3845
21
Zhuo Han, Keming Li, Jinyu Wu, Keyan Wang, Cuipeng Qiu, Hua Ye, Chi Cui, Chunhua Song, Kaijuan Wang, Jianxiang Shi, Peng Wang, Jianying Zhang. Diagnostic value of RNA for hepatocellular carcinoma: a network meta-analysisBiomarkers in Medicine 2021; 15(18): 1755 doi: 10.2217/bmm-2021-0327
22
Shanshan Chen, Hao Chen, Shanshan Gao, Shili Qiu, Hu Zhou, Mingxia Yu, Jiancheng Tu. Differential expression of plasma microRNA‐125b in hepatitis B virus‐related liver diseases and diagnostic potential for hepatitis B virus‐induced hepatocellular carcinomaHepatology Research 2017; 47(4): 312 doi: 10.1111/hepr.12739
23
Ping Luo, Sanyun Wu, Yalan Yu, Xinliang Ming, Shuo Li, Xuelan Zuo, Jiancheng Tu. Current Status and Perspective Biomarkers in AFP Negative HCC: Towards Screening for and Diagnosing Hepatocellular Carcinoma at an Earlier StagePathology & Oncology Research 2020; 26(2): 599 doi: 10.1007/s12253-019-00585-5
24
Yu Liu, Ye Yang, Tianlong Wang, Li Wang, Xin Wang, Tiemin Li, Yue Shi, Yawei Wang. Long non-coding RNA CCAL promotes hepatocellular carcinoma progression by regulating AP-2α and Wnt/β-catenin pathwayInternational Journal of Biological Macromolecules 2018; 109: 424 doi: 10.1016/j.ijbiomac.2017.12.110
25
Zhao Liu, Mi Chen, Lin-Ka Xie, Ting Liu, Zhen-Wei Zou, Yong Li, Peng Chen, Xin Peng, Charlie Ma, Wen-Jie Zhang, Pin-Dong Li. CLCA4 inhibits cell proliferation and invasion of hepatocellular carcinoma by suppressing epithelial-mesenchymal transition via PI3K/AKT signalingAging 2018; 10(10): 2570 doi: 10.18632/aging.101571
26
Yi-Qun Che, Yue Zhang, Han-Bing Li, Di Shen, Wei Cui. Serum KLKB1 as a Potential Prognostic Biomarker for Hepatocellular Carcinoma Based on Data-Independent Acquisition and Parallel Reaction MonitoringJournal of Hepatocellular Carcinoma 2021; : 1241 doi: 10.2147/JHC.S325629
27
Xiaorong Deng, Weiwei Wei, Niangen Huang, Yumeng Shi, Mingwen Huang, Yehong Yan, Dongjian Li, Jilin Yi, Xinbao Wang. Tumor repressor gene chondroadherin oppose migration and proliferation in hepatocellular carcinoma and predicts a good survivalOncotarget 2017; 8(36): 60270 doi: 10.18632/oncotarget.19811
28
Lijun Zhao, Kexin Hu, Jianzhong Cao, Pan Wang, Jun Li, Kewu Zeng, Xiaodong He, Peng-Fei Tu, Tanjun Tong, Limin Han. lncRNA miat functions as a ceRNA to upregulate sirt1 by sponging miR-22-3p in HCC cellular senescenceAging 2019; 11(17): 7098 doi: 10.18632/aging.102240
29
Abeer Ahmed ALrefai, Sara Kamal Rizk, Ahmed Kamal Khamis, Zeinab A Kasemy, Mona Salah Eldin Habieb. Utility of a microRNA panel in diagnosis and prognosis of hepatitis C–associated hepatocellular carcinomaLaboratory Medicine 2023;  doi: 10.1093/labmed/lmad081
30
Ying Cao, Jianbo Cao, Binbin Yu, Shusheng Wang, Lili Liu, Li Tao, Wanping Sun. Berbamine induces SMMC-7721 cell apoptosis via upregulating p53, downregulating survivin expression and activating mitochondria signaling pathwayExperimental and Therapeutic Medicine 2017;  doi: 10.3892/etm.2017.5637
31
Jiali Meng, Yuanchao Wei, Qing Deng, Ling Li, Xiaolong Li. Study on the expression of TOP2A in hepatocellular carcinoma and its relationship with patient prognosisCancer Cell International 2022; 22(1) doi: 10.1186/s12935-021-02439-0
32
Yuheng Zhang, Jun Li, Shuai Wang, Faji Yang, Yuan Zhou, Yang Liu, Wei Zhu, Xiaolei Shi. HBx‑associated long non‑coding RNA activated by TGF‑β promotes cell invasion and migration by inducing autophagy in primary liver cancerInternational Journal of Oncology 2019;  doi: 10.3892/ijo.2019.4908
33
Huifang Peng, Zhijian Yan, Xinhua Zeng, Sheng Zhang, Hongwei Jiang, Heqing Huang, Huiqin Zhuo. Serum and tissue proteomic signatures of patients with hepatocellular carcinoma using 2‑D gel electrophoresisMolecular Medicine Reports 2019;  doi: 10.3892/mmr.2019.10311
34
Maissa El Raziky, Hanan Abdel Hafez, Aisha Elsharkawy, Tarek Ahmed Moneer, Suzan M. EL-Sheikh, Rabab M. Maher, Sahar A. Sharaf. Serum level of cytokeratin 19 as a diagnostic and prognostic marker in patients with HCV-related hepatocellular carcinomaEgyptian Liver Journal 2021; 11(1) doi: 10.1186/s43066-021-00125-4
35
Mizelle D'Silva, Jai Young Cho, Ho-Seong Han, Yoo-Seok Yoon, Hae Won Lee, Jun Suh Lee, Boram Lee, Moonhwan Kim. Long-term surgical outcomes of Non alcoholic fatty liver disease associated hepatocellular carcinomaSurgical Oncology 2022; 41: 101730 doi: 10.1016/j.suronc.2022.101730
36
Fabio Giannone, Nevena Slovic, Patrick Pessaux, Catherine Schuster, Thomas F. Baumert, Joachim Lupberger. Inflammation-related prognostic markers in resected hepatocellular carcinomaFrontiers in Oncology 2023; 13 doi: 10.3389/fonc.2023.1267870
37
Tian Hu, Jincheng Li, Chuhong Zhang, Xiu lv, Sai Li, Sha He, Hanxing Yan, Yixi Tan, Mingsheng Lei, Meiling Wen, Jianhong Zuo. The potential value of microRNA-4463 in the prognosis evaluation in hepatocellular carcinomaGenes & Diseases 2017; 4(2): 116 doi: 10.1016/j.gendis.2017.03.003
38
Fengjuan Cheng, Guanhua Qian, Xianyun Fang, Jingjie Sun, Siyuan Chen, Rongjuan Chen, Shangjing Liu, Zhaodi Li, Kejia Wu, Shiming Jiang, Yong Chen, Ni Tang, Juan Chen, Changzhu Duan. HBx promotes hepatocarcinogenesis by enhancing phosphorylation and blocking ubiquitinylation of UHRF2Hepatology International 2021; 15(3): 707 doi: 10.1007/s12072-021-10172-z
39
Zhikun Lin, Ruiping He, Haifeng Luo, Chang Lu, Zhen Ning, Yuanhang Wu, Chuanchun Han, Guang Tan, Zhongyu Wang. RETRACTED ARTICLE: Integrin-β5, a miR-185-targeted gene, promotes hepatocellular carcinoma tumorigenesis by regulating β-catenin stabilityJournal of Experimental & Clinical Cancer Research 2018; 37(1) doi: 10.1186/s13046-018-0691-9
40
ZhenYu Feng, ZhenYu Ye, JiaMing Xie, Wei Chen, Wei Li, ChunGen Xing. Study on the mechanism of LOXL1-AS1/miR-3614-5p/YY1 signal axis in the malignant phenotype regulation of hepatocellular carcinomaBiology Direct 2021; 16(1) doi: 10.1186/s13062-021-00312-8
41
Gang Chi, Jinhong Pei, Xueqing Li, Xujiong Li, Hui Pang, Jia Cui, Dongkai Wu, Gexi Qu, Yuan He. SMYD5 acts as a potential biomarker for hepatocellular carcinomaExperimental Cell Research 2022; 414(2): 113076 doi: 10.1016/j.yexcr.2022.113076
42
Branislava Ranković, Nina Hauptman. Circulating microRNA Panels for Detection of Liver Cancers and Liver-Metastasizing Primary CancersInternational Journal of Molecular Sciences 2023; 24(20): 15451 doi: 10.3390/ijms242015451
43
Massimiliano Berretta, Carla Cavaliere, Lara Alessandrini, Brigida Stanzione, Gaetano Facchini, Luca Balestreri, Tiziana Perin, Vincenzo Canzonieri. Serum and tissue markers in hepatocellular carcinoma and cholangiocarcinoma: clinical and prognostic implicationsOncotarget 2017; 8(8): 14192 doi: 10.18632/oncotarget.13929
44
Riccardo Di Santo, Maria Vaccaro, Sabrina Romanò, Flavio Di Giacinto, Massimiliano Papi, Gian Ludovico Rapaccini, Marco De Spirito, Luca Miele, Umberto Basile, Gabriele Ciasca. Machine Learning-Assisted FTIR Analysis of Circulating Extracellular Vesicles for Cancer Liquid BiopsyJournal of Personalized Medicine 2022; 12(6): 949 doi: 10.3390/jpm12060949
45
Yang Zhang, Fangfang Jin, Yuan Wu, Bingyu Wang, Jingri Xie, Yu Li, Yujia Pan, Zhaolan Liu, Wenjuan Shen. Prognostic impact of gamma-glutamyl transpeptidase to platelets ratio on hepatocellular carcinoma patients who have undergone surgery: a meta-analysis and systematic reviewEuropean Journal of Gastroenterology & Hepatology 2023; 35(8): 803 doi: 10.1097/MEG.0000000000002572
46
Ling-Juan Luo, Li-Ping Zhang, Chun-Yan Duan, Bei Wang, Na-Na He, Patima Abulimiti, Yan Lin. The inhibition role of miR-22 in hepatocellular carcinoma cell migration and invasion via targeting CD147Cancer Cell International 2017; 17(1) doi: 10.1186/s12935-016-0380-8
47
Si Ying Tang, Ying Xu, Cong Cong Jiao, Meng Hui Jiang, Nan Kong, Hao Ding, Lian Hua Cui, Jin-Mei Piao. Clinical significance of cylindromatosis expression in primary hepatocellular carcinomaArab Journal of Gastroenterology 2023; 24(1): 58 doi: 10.1016/j.ajg.2022.11.001
48
Cunhua Shao, Gongpan Liu, Xiaobin Zhang, Anyun Li, Xingjun Guo. <p>Long Noncoding RNA RMRP Suppresses the Tumorigenesis of Hepatocellular Carcinoma Through Targeting microRNA-766</p>OncoTargets and Therapy 2020; : 3013 doi: 10.2147/OTT.S243736